Innovating Works
FasNaGel: NOVEL THERAPEUTIC NANOHYDROGEL FOR ACUTE AND CHRONIC PAIN TREATMENT TARGETED TO THE NERVES FASCIA I+MED S.COOP. PEQUEÑA tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Worldwide chronic pain conditions are by far the greatest cause of disability. It has an enormous negative impact on quality of life and on...
2018-05-07 - 2018-11-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.